BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16157374)

  • 1. Bilateral ear Sweet's syndrome in a case with relapse acute myeloblastic leukemia.
    Disel U; Paydas S; Yavuz S; Tuncer I; Alpay R
    Leuk Res; 2006 Mar; 30(3):364. PubMed ID: 16157374
    [No Abstract]   [Full Text] [Related]  

  • 2. Sweet's syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment.
    Kumar G; Bernstein JM; Waibel JS; Baumann MA
    Am J Hematol; 2004 Jul; 76(3):283-5. PubMed ID: 15224368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor.
    Uhara H; Saida T; Nakazawa H; Ito T
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S10-2. PubMed ID: 18625369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute febrile neutrophilic dermatitis (Sweet's syndrome) during therapeutic agranulocytosis in acute myeloblastic leukemia].
    Torri O; Ruto F; Dierick A; Labeille B; Lok C; Desablens B; Denoeux JP
    Ann Dermatol Venereol; 1993; 120(12):884-8. PubMed ID: 8074347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
    Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R
    Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized comparison of immediate versus delayed application of G-CSF in induction therapy for patients with acute myeloid leukemia unfit for intensive chemotherapy.
    von Lilienfeld-Toal M; Hahn-Ast C; Kirchner H; Flieger D; Dölken G; Glasmacher A
    Haematologica; 2007 Dec; 92(12):1719-20. PubMed ID: 18056004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of IDA-FLAG programme in the treatment of recurrent acute myeloblastic leukaemia--preliminary report.
    Łuczyński W; Muszyńska-Rosłan K; Krawczuk-Rybak M; Kuźmicz M; Iwaszkiewicz-Pawłowska A; Kaliszewski J
    Med Sci Monit; 2001; 7(1):125-9. PubMed ID: 11208507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sweet's syndrome masquerading as facial cellulitis.
    Crum NF; Higginbottom PA; Fehl FC; Graham BS
    Cutis; 2003 Jun; 71(6):469-72. PubMed ID: 12839258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sweet's syndrome: dilemma in febrile neutropenic patient with acute myeloid leukemia.
    Ozcelik T; Ozkocaman V; Ali R; Ozkalemkas F; Bulbul-Baskan E; Yazici B; Ozkan A; Tunali A
    Leuk Res; 2006 Nov; 30(11):1466-8. PubMed ID: 16540169
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of relapsing neuro-Sweet's disease with corticosteroid and dapsone combination therapy.
    Fukae J; Noda K; Fujishima K; Wada R; Yoshiike T; Hattori N; Okuma Y
    Clin Neurol Neurosurg; 2007 Dec; 109(10):910-3. PubMed ID: 17889430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
    Yavuz S; Paydas S; Disel U; Sahin B
    Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: a prospective, multicenter phase II study.
    Kim H; Park JH; Lee JH; Lee JH; Joo YD; Lee WS; Bae SH; Mo Ryoo H; Lee KH;
    Am J Hematol; 2009 Mar; 84(3):161-6. PubMed ID: 19195034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wernicke's Encephalopathy in an Acute Myeloid Leukemia Patient: A Case Study.
    Maden M; Pamuk G; Çelik Y; Ünlü E
    Turk J Haematol; 2016 Mar; 33(1):78-9. PubMed ID: 27020725
    [No Abstract]   [Full Text] [Related]  

  • 14. Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.
    Keating MJ; Estey E; Kantarjian H; Plunkett W; O'Brien S; Koller C; Beran M; Freireich EJ
    Leukemia; 1992; 6 Suppl 2():78-80. PubMed ID: 1578950
    [No Abstract]   [Full Text] [Related]  

  • 15. Paraneoplastic Sweet's syndrome and the pathergy phenomenon.
    Awan F; Hamadani M; Devine S
    Ann Hematol; 2007 Aug; 86(8):613-4. PubMed ID: 17468870
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sweet's syndrome in the post-chemotherapy granulocytopenic phase of an acute leukemia].
    Abella E; Ribera JM; Fernándiz C; Flores A; Millá F
    Rev Clin Esp; 1991 Apr; 188(6):319-20. PubMed ID: 1780536
    [No Abstract]   [Full Text] [Related]  

  • 17. Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.
    Lee SH; Abebe L; Paietta E; Einzig A; Wiernik PH
    Am J Hematol; 2009 Jul; 84(7):455-7. PubMed ID: 19507211
    [No Abstract]   [Full Text] [Related]  

  • 18. Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia.
    Montillo M; Ricci F; Tedeschi A; Cafro AM; Nosari AM; Nichelatti M; Marbello L; Morra E
    Leuk Res; 2009 Aug; 33(8):1072-8. PubMed ID: 19187960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dacryoadenitis associated with subcutaneous Sweet's syndrome in a patient with acute myeloid leukemia.
    Maalouf T; Angioi K; Ssi-Yan-Kai I; Vernerey F; Witz B; George J
    Orbit; 2005 Mar; 24(1):55-7. PubMed ID: 15764119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Treatment With Total Skin Electron Beam Therapy in a Child With Isolated Cutaneous Relapsed AML.
    Karapinar DY; Kamer SA; Karadaş N; Anacak Y; Delcastello BE; Balkan C; Kavakli K; Aydinok Y
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):e372-4. PubMed ID: 26181423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.